The race to be the first to make a coronavirus vaccine is over, but that doesn't mean the competition has ended. Its candidate, INO-4800, will only start its phase 3 clinical trials sometime this summer. If Inovio's jab doesn't cut the mustard, it might not even get approved. The https://claytonqqqnm.wssblogs.com/4994511/melhor-opção-para-telas-curvas-uma-visão-geral